Live feed
·
INSIDERFilingvia Quantisnow
Windtree Therapeutics Inc. logo

Windtree Therapeutics (WINT) executive Hamill received 66,300 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

John P. Hamill (executive at Windtree Therapeutics Inc., WINT) reported that they received 66,300 shares on Mar 4, 2022. After these transactions the filing shows 69,800 shares held directly.

Reporting person
Hamill John P.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Mar 4, 2022Grant or award (A)Common Stock1+66,300--69,800 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Mar 4, 2022Grant or award (A)Employee Stock Option (Right to Buy)On 99,600 Common Stock2+99,600--99,600 direct

Holdings before and after

  • Common Stock: 3,500 to 69,800 direct
  • Employee Stock Option (Right to Buy): 0 to 99,600 direct

Footnotes from the filing

  1. 1. These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date.
  2. 2. This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Hamill report in this WINT Form 4?

John P. Hamill (executive at Windtree Therapeutics Inc., WINT) reported that they received 66,300 shares on Mar 4, 2022. After these transactions the filing shows 69,800 shares held directly.

How many WINT shares does Hamill hold after this filing?

The filing shows 69,800 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for WINT

Earlier insider filings at WINT

Quantisnow market dataNASDAQ
Windtree Therapeutics Inc. logo
WINT
Windtree Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for WINT

Follow WINT and get a push notification the moment its next story breaks.

Full WINT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WINT (Windtree Therapeutics Inc.) and more on Quantisnow.